IPO News | Annoroad Submits Listing Application to HKEX for the Third Time

According to a disclosure by the Hong Kong Stock Exchange on April 15, Annoroad Gene Technology (Beijing) Co., Ltd. (referred to as Annoroad) submitted its listing application for the third time to the main board of the Hong Kong Stock Exchange. CCB International and Guotai Haitong are acting as its joint sponsors.

Zhitong FinanceApr 16 06:24

At a Glance: March's Hottest IPOs - Shangmi Technology Approved! Four New Stocks, Including ZhaoWei Electromechanical and EastControl, Undergoing Enthusiastic Subscription.

Hello, fellow investors! The New Stock Observer is here to provide updates on the popular HK IPOs in March and throughout 2026. Fellow investors, check it out now!

Futu NewsFeb 28 09:55

At a Glance: January's Hottest IPOs: First of the New Year! Biren Technology listed on the Hong Kong Stock Exchange on January 2nd, with 10 new stocks including Zhipu, MINIMAX, and TianShuZhiXin in active subscription.

Hello, fellow investors! The Futu IPO Assistant is here to provide you with the most popular IPOs in HK for January and 2026. Fellow investors, come and check them out!

Futu NewsDec 31, 2025 15:57

KPMG: Hong Kong regains top spot in global IPO fundraising this year, with an estimated HKD 272.1 billion raised.

KPMG's latest report, 'Review of the 2025 IPO Market in Mainland China and Hong Kong and Outlook for 2026,' highlights that Hong Kong regained its position as the top global IPO market in 2025, marking its return to the leading spot since 2019. The number of A+H share listings this year reached a new high, accounting for over half of the total funds raised throughout the year, propelling Hong Kong’s IPO market performance to rank first globally. As of December 7, the number of listing applications in Hong Kong hit a record high, with over 300 filings in total, including 92 A+H share listing applications. The report notes that, this year, the global IPO market collectively raised USD 158.4 billion through 1,227 listings.

AASTOCKSDec 10, 2025 17:41

China DNA Sequencing Research Report 2025: Market to Reach $3.1 Billion by 2030, Dominated by BGI, Novogene, Berry Genomics, Annoroad Gene Technology, and Burning Rock Dx

Yahoo FinanceOct 20, 2025 22:45

IPO Outlook | With a HKD 4 billion valuation, can Annoroad become the 'BGI of Hong Kong' after filing for listing again?

In recent years, structural changes in the domestic NIPT market, coupled with industry-wide centralized procurement, have brought an end to the high-growth era of the NIPT market, ushering it into a new phase characterized by competition within an existing market. Annoroad, as the third-largest company in China’s NIPT sector by market share, has chosen this period of industry adjustment to knock on the doors of the Hong Kong Stock Exchange.

Zhitong FinanceOct 10, 2025 10:27